The Hungarian drug market was affected by the COVID-19 crisis but it is far from being disrupted – read an English summary of an online survey conducted by Drugreporter among its Hungarian readers.
Boosters – (Not so) New Drugs in Poland
The members of Drugreporter’s video advocacy network produced a movie about the new generation of synthetic drugs that conquered Poland in 2008 – and are still popular.
Reducing the Harms of a Broken System: Social Justice Demands During COVID-19
In this time of crisis, harm reduction activists must go beyond their regular demands and urge governments to act quickly to prevent a public health crisis transforming into a social collapse (Greek translation).
Cannabis Reform Around the World in 2020
Drugreporter’s video advocacy team gives you a global overview of cannabis reform – watch our interviews with key activists from 6 countries where major reforms are underway!
Harm Reduction Must Go On: Position of European Harm Reduction Networks on COVID-19
The Correlation European Harm Reduction Network and the Eurasian Harm Reduction Association published a joint position on the continuity of harm reduction services during the COVID-19 crisis. (PDF: English Russian German Portuguese Spanish Hungarian Polish Czech Montenegrin)
Arild Knutsen: An Open Letter on Covid-19 and People Who Use Drugs
This letter was written by Arild Knutsen, a Norwegian drug user activist, to raise awareness of how the Covid-19 epidemic can affect people who use drugs – and how to protect them.
Harm Reduction Responses to COVID-19 in Europe: Regularly Updated Infopage
On this info page Drugreporter provides regular updates about resources and news on how harm reduction service providers respond to the COVID-19 Epidemic.
4 Short Videos about Recent Developments in Global Drug Policies
The Commission on Narcotic Drugs (CND) is the largest international drug policy decision making forum in the world. This year, at the 63rd session of the CND, our video advocacy team produced four short video reports to inform the public about some of the major developments.
How to Make a New EU Drugs Strategy?
The EU Drugs Strategy (2013-20) expires this year and there are huge gaps in its implementation. Policy documents that are not enforced damage the credibility of the EU. To avoid this, we should revise the paradigm and create a new framework for actions.
Cannabis Legalisation Has Arrived in Europe: Civil Society Should Not Be Silent
It is time for drug professionals, including the harm reduction community, to have a say about the upcoming regulation of the European cannabis market. If not, we miss an important historical opportunity to shape the future.